We accept credit card paymentsWire · ACH · Zelle · Credit card

Research Use Only. FOXO4-DRI is sold as a chemical reagent for in-vitro laboratory research. It is not a drug, supplement, or compounded preparation, and it is not for human or veterinary use. It must be handled by qualified professionals. Wholesale Peptide Supply is not a pharmacy or compounding facility under 503A or 503B.

Anti-Aging & LongevityCAS 2460055-10-9

Wholesale FOXO4-DRI — Bulk Research Supply

Buy FOXO4-DRI wholesale and in bulk from a US-based research peptide supplier. Every lot is sourced in the USA and third-party tested via HPLC/MS. Bulk FOXO4-DRI is quoted by dose and volume from a 100-vial mix-and-match minimum; volume pricing is earned per compound at 100 kits.

FOXO4-DRI is a retro-inverso peptide that competes with endogenous FOXO4 for p53 binding. It is studied as a senolytic research tool in laboratory models of cellular senescence.

Wholesale FOXO4-DRI 10mg lyophilized vial — Wholesale Peptide Supply
FOXO4-DRI 10mg lyophilized vial as supplied. Labeling is customizable for private-label orders.

Wholesale Catalog

Available Doses

Published per-vial wholesale pricing for FOXO4-DRI. Sold in kits of 10 vials with a 100-vial order minimum you can mix and match across compounds; volume pricing applies at 1,000+ vials. Contact us for larger or custom-volume quotes — typically answered within 10 minutes during business hours.

FOXO4-DRI 10mg50% off

WPSFX410 · CAS 2460055-10-9 · Anti-Aging & Longevity

$149.50$74.75/vial · 50% off at any volumeWhile supplies last

Discontinued — limited to stock on hand. Once it's gone, it's gone. Sold in kits of 10 vials · 100-vial order minimum (mix & match across compounds).

Quantity
10 vials
1 kit
Request a custom quote

Overview

FOXO4-DRI is a retro-inverso peptide that competes with endogenous FOXO4 for p53 binding. It is studied as a senolytic research tool in laboratory models of cellular senescence.

History

Designed by Baar and colleagues at Erasmus University Medical Center from the FOXO4 domain that binds p53, synthesized with D-amino acids in reverse order so the peptide resists proteolysis while retaining binding activity.

What retro-inverso means, and why it is the point

FOXO4-DRI is not a conventional peptide analogue. The name records its construction: D-amino acids, Retro-Inverso. The sequence is reversed and every residue is built from the D-enantiomer rather than the L-form found in natural proteins.

Running both changes together is what makes the design work. Reversing the sequence while inverting the chirality leaves the side-chain topology approximately where it was, so the molecule still presents the interaction surface it needs to — but proteases, which recognise L-amino-acid backbones, largely do not act on it. The result is a peptide that keeps the binding geometry and loses most of the degradation.

Functionally it competes with endogenous FOXO4 for p53 binding. In senescent cells FOXO4 sequesters p53 in PML nuclear bodies; displacing it is the mechanism behind the compound's use as a senolytic research tool.

This matters for ordering because a conventionally synthesised L-form of the same sequence is a different reagent that will not behave the same way. Identity confirmation on the Certificate of Analysis should be read with that in mind.

Key Areas of Research

  • FOXO4-p53 interaction and PML nuclear bodies
  • Senescent cell apoptosis models
  • Retro-inverso peptide design and protease resistance
  • Comparative studies vs. small-molecule senolytics

References

  1. Baar M.P. et al. (2017). Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell, 169(1):132–147.
  2. Bourgeois B. & Madl T. (2018). Regulation of cellular senescence via the FOXO4-p53 axis. FEBS Lett, 592(12):2083–2097.

FOXO4-DRI — Frequently Asked Questions

What is FOXO4-DRI?
FOXO4-DRI is a retro-inverso peptide that competes with endogenous FOXO4 for p53 binding. It is studied as a senolytic research tool in laboratory models of cellular senescence.
What is the CAS number for FOXO4-DRI?
The CAS number for FOXO4-DRI is 2460055-10-9. Its molecular formula is — (MW 2,957.2 g/mol).
What doses of FOXO4-DRI are available wholesale?
Wholesale Peptide Supply stocks FOXO4-DRI in 10mg. Wholesale pricing is provided by quote based on order volume across 100–1,000 vials.
Is FOXO4-DRI third-party tested?
Yes. Every lot of FOXO4-DRI is tested by an independent third-party laboratory using HPLC/MS, and a per-lot Certificate of Analysis documenting identity and purity is included with every order at no charge, issued in the name of Wholesale Peptide Supply.
Is FOXO4-DRI for human use?
No. FOXO4-DRI is sold strictly as a chemical reagent for in-vitro laboratory research and is not for human or veterinary use. Wholesale Peptide Supply is not a pharmacy or compounding facility.
How do I get wholesale pricing for FOXO4-DRI?
Request a quote through our contact form or open a wholesale account. An account manager replies with volume pricing and lead times, typically within 10 minutes during business hours.
Can I order FOXO4-DRI in bulk?
Yes. FOXO4-DRI is available for bulk and wholesale orders, quoted by dose and volume, with the lower price earned per compound at 100 kits (1,000 vials). Submit the doses and quantities you need for a bulk quote.

Related Compounds